RESUMEN
The present study investigated the in vitro and the in vivo interactions among azithromycin, clarithromycin, minocycline, and tigecycline against Pythium insidiosum. In vitro antimicrobial activities were determined by the broth microdilution method in accordance with CLSI document M38-A2, and the antibiotic interactions were assayed using the checkerboard MIC format. In vivo efficacy was determined using a rabbit infection model. The geometric mean MICs of azithromycin, clarithromycin, minocycline, and tigecycline against P. insidiosum were, respectively, 1.91, 1.38, 0.91, and 0.79 µg/ml. By checkerboard testing, all combinations resulted in in vitro synergistic interactions (>60%). Antagonism was not observed. The in vivo studies showed that azithromycin (20 mg/kg/day twice daily) alone or in combination with minocycline (10 mg/kg/day twice daily) significantly decreased the fungal burden. This study demonstrates that azithromycin possesses potent curative efficacy against subcutaneous pythiosis in the rabbit model.
Asunto(s)
Antifúngicos/farmacología , Azitromicina/farmacología , Claritromicina/farmacología , Minociclina/análogos & derivados , Minociclina/farmacología , Pitiosis/tratamiento farmacológico , Pythium/efectos de los fármacos , Animales , Esquema de Medicación , Sinergismo Farmacológico , Quimioterapia Combinada , Pruebas de Sensibilidad Microbiana , Análisis Multivariante , Pitiosis/microbiología , Pitiosis/patología , Pythium/genética , Pythium/crecimiento & desarrollo , Pythium/aislamiento & purificación , Conejos , Piel/efectos de los fármacos , Piel/microbiología , Piel/patología , TigeciclinaRESUMEN
We have determined the in vitro activity of several antibacterial and antifungal drugs against Pythium insidiosum using broth microdilution (BMD), disk diffusion, and Etest methods. The largest zones of inhibition (disk diffusion) and the lowest BMD and Etest MICs were observed for azithromycin, clarithromycin, linezolid, mupirocin, doxycycline, minocycline, and tigecycline. The in vitro activities observed suggest that antibacterials, which act by inhibiting protein synthesis, are promising candidate therapies for the treatment of pythiosis.
Asunto(s)
Antibacterianos/farmacología , Antifúngicos/farmacología , Pythium/efectos de los fármacos , Acetamidas/farmacología , Azitromicina/farmacología , Claritromicina/farmacología , Doxiciclina/farmacología , Linezolid , Pruebas de Sensibilidad Microbiana , Minociclina/análogos & derivados , Minociclina/farmacología , Mupirocina/farmacología , Oxazolidinonas/farmacología , Pythium/crecimiento & desarrollo , TigeciclinaRESUMEN
We describe here the in vitro activities of azithromycin, clarithromycin, minocycline, or tigecycline alone and in combination with amphotericin B, itraconazole, terbinafine, voriconazole, anidulafungin, caspofungin, or micafungin against 30 isolates of the oomycete Pythium insidiosum. The assays were based on the CLSI M38-A2 technique and the checkerboard microdilution method. The main synergisms observed were through the combination of minocycline with amphotericin B (73.33%), itraconazole (70%), and micafungin (70%) and of clarithromycin with micafungin (73.33%).